2020 Annual Meeting - Geriatric Oncology: What Do Radiation Oncologists Need to Know
In this interactive course, four expert speakers will fulfill the above educational needs by: 1) Highlighting ways in which older adults differ from younger healthier patients, and how they are under-represented in standard setting trials. 2) Describing how objective clinical and radiologic findings including sarcopenia may impact treatment outcomes. 3) Detailing how geriatric assessment tools can be used to improve patient care. 4) Educating physicians and nurses on how to implement these screening tools into their own clinics, and giving specific examples of how the Geriatric Assessment impacted treatment choices within a radiation oncology clinic.
The activity is designed to meet the interests of radiation oncologists, medical oncologists, surgeons, nurses, and radiation oncology residents.
- Describe barriers to care for older adults with cancer.
- Determine the difference between a "fit" older adult versus a "frail" older adult.
- Use Geriatric Assessment screening tools in their own clinics to predict median life expectancy and make treatment decisions.
- Rachel A. Freedman, MD, MPH is employed at Dana Farber Cancer Institute and has no financial relationships with a commercial interest.
- Grant R. Williams, MD is employed at University of Alabama Birmingham Department of Medicine and receives compensation from Carevive Systems.
- Allison Magnuson, DO is employed at University of Rochester Medical Center, Department of Medicine and has no financial relationships with a commercial interest.
- Noam A. VanderWalde, MD is employed at West Cancer Center and Research Institute, Department of Radiation Oncology and has investment interest from Vector Oncology/ Concerto Health AI.
The person(s) above served as the developer(s) of this activity. Additionally, the Education and CME/MOC Committees had control over the content of this activity.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.25 Certificate of AttendanceThis activity was designated for 1.25 AMA PRA Category 1 Credit™.
- 1.25 SA-CME
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.
The American Society for Radiation Oncology (ASTRO) designates this for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.25 self-assessment credits.
• No refunds, extensions or substitutions will be made for those registrants who, for any reason, were unable to attend or were tardy for the session.
• No credits will be granted and no refunds, exchanges or transfers will be given to those who do not pass.
• ASTRO staff cannot make modifications to your submitted materials.
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.